Skip to main content
. 2021 Oct 29;28(2):298–307. doi: 10.1158/1078-0432.CCR-21-2007

Figure 4.

Figure 4. TGCT biopsy-targeted RNA-seq identified abnormal CSF1 transcripts. Ten specimens showed evidence of alteration at exon 8 or within the 3′UTR, with 6 strong-evidence events (A) and 4 low-confidence events (B). CA11, carbonic anhydrase 11; CD101, CD101 molecule; CD99, CD99 molecule (Xg blood group); CDH13, cadherin 13; Chr, chromosome; CSF1, colony-stimulating factor 1; ENG, endoglin; FN1, fibronectin 1; SM, sample; TGCT, tenosynovial giant cell tumor; TM, transmembrane; UTR, untranslated region.

TGCT biopsy-targeted RNA-seq identified abnormal CSF1 transcripts. Ten specimens showed evidence of alteration at exon 8 or within the 3′UTR, with 6 strong-evidence events (A) and 4 low-confidence events (B). CA11, carbonic anhydrase 11; CD101, CD101 molecule; CD99, CD99 molecule (Xg blood group); CDH13, cadherin 13; Chr, chromosome; CSF1, colony-stimulating factor 1; ENG, endoglin; FN1, fibronectin 1; SM, sample; TGCT, tenosynovial giant cell tumor; TM, transmembrane; UTR, untranslated region.